Anti-Fibrinolytic

From Protocopedia
Revision as of 20:44, 27 August 2018 by Treloars (talk | contribs) (Created page with "==Section 8 - MEDICATION GUIDELINES== ===8.19 ANTI-FIBRINOLYTICS=== ====Tranexamic Acid (TXA)==== '''DESCRIPTION''' * Inhibits both plasminogen activation and plasmin activi...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Section 8 - MEDICATION GUIDELINES

8.19 ANTI-FIBRINOLYTICS

Tranexamic Acid (TXA)

DESCRIPTION

  • Inhibits both plasminogen activation and plasmin activity, thus preventing clot break-down rather than promoting new clot formation. With massive bleeding this may help stabilize clot formation and decrease extravascular bleeding.

INDICATIONS

CONTRAINDICATIONS

  • Isolated head injury
  • Known hypersensitivity
  • Age less than 16 years old
  • Known pregnancy

PRECAUTIONS

  • Rapid injection can cause hypotension

DOSAGE

  • 1000 mg of TXA mixed in 100 ml or 250 ml of normal saline infused via IO or IV over 10 minutes.
Retrieved from "http://roaddoc.com/scems/index.php?title=Anti-Fibrinolytic&oldid=1151"